Oral immunogenicity of the plant proteinase bromelain

International Immunopharmacology

Volumn 6, Issue 13-14, 2006, Pages 2038-2046

  Hale, Laura P ^a   Fitzhugh, David J ^a   Staats, Herman F ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Adjuvant; Alpha 2 macroglobulin; Mucosal immunity; Proteolytically active antigens

Indexed keywords

BROMELAIN; FREUND ADJUVANT; INTERLEUKIN 10; LYSOZYME; OVALBUMIN; PROTEINASE; TRYPSIN;

ADJUVANT THERAPY; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; IMMUNE RESPONSE; IMMUNOGENICITY; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; STATISTICAL SIGNIFICANCE; WILD TYPE;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, ORAL; ANANAS; ANIMALS; BROMELAINS; CHOLERA TOXIN; FECES; FEMALE; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTERLEUKIN-10; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MURAMIDASE; OVALBUMIN; PEPTIDE HYDROLASES; PLANT STEMS; SALIVA; TRYPSIN; VACCINATION;

EID: 33845187772     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2006.08.007     Document Type: Article

References (29)

1. Hale L.P., Greer P.K., Trinh C.T., and Gottfried M.R. Treatment with oral bromelain decreases colonic inflammation in the IL-10-deficient murine model of inflammatory bowel disease. Clin Immunol 116 (2005) 135-142
2. Kelly G.S. Bromelain: a literature review and discussion of its therapeutic applications. Altern Med Rev 1 (1996) 243-257
3. Castell J.V., Friedrich G., Kuhn C.S., and Poppe G.E. Intestinal absorption of undegraded proteins in men: presence of bromelain in plasma after oral intake. Am J Physiol 273 (1997) G139-G146
4. Hale L.P. Proteolytic activity and immunogenicity of oral bromelain within the gastrointestinal tract of mice. Int Immunopharmacol 4 (2004) 255-264
5. Hale L.P., Greer P.K., Trinh C.T., and James C.L. Proteinase activity and stability of natural bromelain preparations. Int Immunopharmacol 5 (2005) 783-793
6. Gailhofer G., Wilders-Truschnig M., Smolle J., and Ludvan M. Asthma caused by bromelain: an occupational allergy. Clin Allergy 18 (1988) 445-450
7. Raison-Peyron N., Roulet A., Guillot B., and Guilhou J.J. Bromelain: an unusual cause of allergic contact dermatitis. Contact Dermatitis 49 (2003) 218-219
8. Hale L.P., and Haynes B.F. Bromelain treatment of human T cells removes CD44, CD45RA, E2/MIC2, CD6, CD7, CD8, and Leu 8/LAM1 surface molecules and markedly enhances CD2-mediated T cell activation. J Immunol 149 (1992) 3809-3816
9. Xu-Amano J., Kiyono H., Jackson R.J., Staats H.F., Fujihashi K., Burrows P.D., et al. Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosal associated tissues. J Exp Med 178 (1993) 1309-1320
10. Staats H.F., Nichols W.G., and Palker T.J. Mucosal immunity to HIV-1: systemic and vaginal antibody responses after intranasal immunization with the HIV-1 C4/V3 peptide T1SP10 MN(A). J Immunol 157 (1996) 462-472
11. Nedrud JG, Sigmund N. Cholera toxin as a mucosal adjuvant: III. Antibody responses to nontarget dietary antigens are not increased. Regional Immunol 1990/1991;3:217-222.
12. Mynott T.L., Crossett B., and Prathalingam S.R. Proteolytic inhibition of Salmonella enterica serovar typhimurium-induced activation of the mitogen-activated protein kinases ERK and JNK in cultured human intestinal cells. Infect Immun 70 (2002) 86-95
13. Engwerda C.R., Andrew D., Murphy M., and Mynott T.L. Bromelain activates murine macrophages and natural killer cells in vitro. Cell Immunol 210 (2001) 5-10
14. Desser L., Rehberger A., and Paukovits W. Proteolytic enzymes and amylase induce cytokine production in human peripheral blood mononuclear cells in vitro. Cancer Biother 9 (1994) 253-263
15. Mynott T.L., Ladhams A., Scarmato P., and Endwerda C.R. Bromelain, from pineapple stems, proteolytically blocks activation of extracellular regulated kinase-2 in T cells. J Immunol 163 (1999) 2568-2575
16. Manhart N., Akomeah R., Bergmeister H., Spittler A., Ploner A., and Roth E. Administration of proteolytic enzymes bromelain and trypsin diminish the number of CD4+cells and the interferon-γ response in Peyer's patches and spleen in endotoxemic balb/c mice. Cell Immunol 215 (2002) 113-119
17. Roep B.O., van den Engel N.K., van Halteren A.G.S., Duinkerken G., and Martin S. Modulation of autoimmunity to beta-cell antigens by proteases. Diabetologia 45 (2002) 686-692
18. Secor Jr. E.R., Carson IV W.F., Cloutier M.M., Guernsey L.A., Schramm C.M., Wu C.A., et al. Bromelain exerts anti-inflammatory effects in an ovalbumin-induced murine model of allergic airway disease. Cell Immunol 237 (2005) 68-75
19. Hale L.P., Greer P.K., and Sempowski G.D. Bromelain treatment alters leukocyte expression of cell surface molecules involved in cellular adhesion and activation. Clin Immunol 104 (2002) 183-190
20. Chu C.T., Oury T.D., Enghild J.J., and Pizzo S.V. Adjuvant-free in vivo targeting. Antigen delivery by alpha 2-macroglobulin enhances antibody formation. J Immunol 152 (1994) 1538-1545
21. Cianciolo G.J., Enghild J.J., and Pizzo S.V. Covalent complexes of antigen and α2-macroglobulin: evidence for dramatically-increased immunogenicity. Vaccine 20 (2002) 554-562
22. Liao H.X., Cianciolo G.J., Staats H.F., Scearce R.M., Lapple D.M., Stauffer S.H., et al. Increased immunogenicity of HIV envelope subunit complexed with alpha2-macroglobulin when combined with monophosphoryl lipid A and GM-CSF. Vaccine 20 (2002) 2396-2403
23. Hart J.R., Gunn M.D., and Pizzo S.V. A CD91-positive subset of CD11c+blood dendritic cells: characterization of the APC that functions to enhance adaptive immune responses against CD91-targeted antigens. J Immunol 172 (2004) 70-78
24. Al-Rasheed A., Scheerens H., Rennick D.M., Fletcher H.M., and Tatakis D.N. Accelerated alveolar bone loss in mice lacking interleukin-10. J Dent Res 82 (2003) 632-635
25. Pederson E.D., Stanke S.R., Whitener S.J., Sebastiani P.T., Lamberts B.L., and Turner D.W. Salivary levels of alpha-2-macroglobulin, alpha-1-antitrypsin, C-reactive protein, cathepsin G and elastase in humans with or without destructive periodontal disease. Arch Oral Biol 40 (1995) 1151-1155
26. Rosin M., Benjamin P., Rogers P., Gibson M., Van Leuven F., Johnson N.W., et al. Elevated conversion of alpha-2-macroglobulin to the complexed form in gingival crevicular fluid from adult periodontitis patients. J Periodontal Res 30 (1995) 436-444
27. Condacci I., Cimasoni G., and Ahmad-Zadeh C. Alpha 2-macroglobulin in sulci from healthy and inflamed human gingivae. Infect Immun 36 (1982) 66-71
28. Giannopoulou C., Di Felice R., Andersen E., and Cimasoni G. Synthesis of alpha 2-macroglobulin in human gingiva: a study of the concentration of macroglobulin and albumin in gingival fluid and serum. Arch Oral Biol 35 (1990) 13-16
29. Wu SM, Pizzo SV. Proteinase inhibitors: α-macroglobulins and kunins. In Hemostasis and thrombosis: basic principles and clinical practice. In: Colman RW, Hirsh J, Marder VJ, Salzman EW, editors. Fourth edition, JB Lippincott, Williams and Wilkins, pp. 367-386, 2000.